BICX
BioCorRx Inc.
Customer concentration
— top 2 customers 99% of revenue
2 customers — 100% of receivables (At March 31, 2026)
“At March 31, 2026, two customers accounted for 100% of the Company’s total accounts receivable with an aggregate amount of $330,348.”
2 customers — 99% of revenue (the three months ended March 31, 2026)
“The Company’s revenues earned from sale of products and services for the three months ended March 31, 2026 included 99% from two customers of the Company’s total revenues.”
Company with tickers: BICX
Market Cap
$9.88M
Shares Outstanding
29,055,547
CIK
1443863
Website
Visit website
Investor Relations
Investor relations
Income-statement, balance-sheet and cash-flow figures extracted from the company's SEC filings — 10-K annual and 10-Q quarterly reports — and standardised for comparison across periods.
| Line Item | Value | Unit | Period End | Form | Filed |
|---|---|---|---|---|---|
| Revenue | $214,539 | USD | 2026-03-31 | 10-Q | 2026-05-15 |
| Revenue (ASC 606) | — | ||||
| Interest & Dividend Income | — | ||||
| Net Interest Income | — | ||||
| Noninterest Income | — | ||||
| Total Net Revenue | — | ||||
| Premiums Earned (Net) | — | ||||
| Cost of Revenue | $25,184 | USD | 2026-03-31 | 10-Q | 2026-05-15 |
| Gross Profit | — | ||||
| Operating Expenses | $1,170,539 | USD | 2026-03-31 | 10-Q | 2026-05-15 |
| Research & Development | $352,333 | USD | 2026-03-31 | 10-Q | 2026-05-15 |
| Operating Income | $-956,000 | USD | 2026-03-31 | 10-Q | 2026-05-15 |
| Net Income | $-831,227 | USD | 2026-03-31 | 10-Q | 2026-05-15 |
| EPS (Basic) | $0.34 | USD/shares | 2026-03-31 | 10-Q | 2026-05-15 |
| EPS (Diluted) | $-0.03 | USD/shares | 2026-03-31 | 10-Q | 2026-05-15 |